新利尿合剂在妊娠高血压综合征患者中的应用价值分析  

Application value analysis of new diuretic mixture in patients with pregnancy-hypertension syndrome

作　　者：刘学燕 

机构地区：[1]邢台市威县人民医院妇产科,河北邢台054700

出　　处：《中国医药导报》2011年第12期78-79,共2页China Medical Herald

摘　　要：目的:探讨新利尿合剂在妊高症患者中的应用价值。方法:选择2006年1月～2009年6月我院收治的136例妊高症孕产妇,观察组(n=86)应用新利尿合剂,对照组(n=50)应用硫酸镁。比较两组平均动脉压(MAP)变化、分娩方式、产后出血及围生儿结局。结果:观察组总有效率为88.4%(76/86),对照组为86.0%(43/50)(P>0.05);观察组MAP下降(3.3±0.7)更为显著,剖宫产率(15.1%)和产后出血率(2.3%)与对照组无明显差异(40.0%、16.0%)(均P<0.05);观察组新生儿窒息、围生儿死亡率(11.1%、4.4%)与对照组比无明显差异(16.4%、5.5%)(P>0.05)。结论:新利尿合剂治疗妊高症疗效并不弱于硫酸镁,但降压效果更为显著,能明显降低剖宫产率和产后出血率,有重要的临床应用价值。Objective： To investgate the application value of new diuretic mixture in patients with pregnancy-hypertension syndrome. Methods： 136 maternals with pregnancy-hypertension syndrome treated in our hospital from January 2006 to June 2009 were selected, the observation group （n=86） were given with new diuretic mixture, the control group （n=50） were given with magnesium sulfate. MAP changes, mode of delivery, postpartum hemorrhage and perinatal outcome were compared between two groups. Results： Total effective rate in the observation group was 88.4% （76/86）, the control group was 86.0% （43/50） （P〉0.05）; MAP decreased more significantly in observation group, Lower rate of cesarean section and postpartum haemorrhage （all P〈0.05）; asphyxia of newborn, perineonate mortality rates in observation group had no difference with those in control group （P〉0.05）. Conclusion： The new diuretic mixture in patients with pregnancy-hypertension syndrome is not weaker than magnesium sulfate, but the blood pressure effect is more significant, can significantly reduce the cesarean section rate and rate of postpartum hemorrhage, has important clinical value.

关 键 词：妊娠高血压综合征 新利尿合剂 价值 

分 类 号：R714.246[医药卫生—妇产科学]